AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus...

BMC Cancer 2020 / 12 Vol. 20; Iss. 1

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07169-6
Date:
December, 2020
File:
PDF, 772 KB
2020
Conversion to is in progress
Conversion to is failed